Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression.

Journal of hepatology - 1 Dec 2024

Mendoza Yuly P, Tsouka Sofia, Semmler Georg, Seubnooch Patcharamon, Freiburghaus Katrin, Mandorfer Mattias, Bosch Jaime, Masoodi Mojgan, Berzigotti Annalisa

Abstract excerpt

BACKGROUND & AIMS: Regression of cirrhosis has been observed in patients with viral and non-viral etiologies of liver disease in whom the underlying cause of liver injury was effectively suppressed. However, the understanding of the factors contributing to reversibility of fibrosis and cirrhosis is limited. Our aims were to assess clinical factors, perform genotyping of known variants, and comprehensive metabolic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chronic Disease

Share to Genotype

Share to Liver Cirrhosis

Share to Phenotype

Share to Pilot Projects

Source

Identifiers

PMID: 38944391
DOI: 10.1016/j.jhep.2024.06.028

Genes

GCKR
IMPACT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression.PMID 38944391Read ↗

Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertensionSemantic proximity Read ↗

Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertensionSemantic proximity Read ↗

Early Identification of At-Risk Patients: Proteomic Signature Predicts Progression to Decompensated CirrhosisSemantic proximity Read ↗

Germline Variants Influence Chronic Liver Disease Progression through Distinct PathwaysSemantic proximity Read ↗

Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failureSemantic proximity Read ↗

Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis.Semantic proximity Read ↗

Persistent steatosis retards fibrosis regression during anti-HBV treatment in patients with chronic HBV infectionSemantic proximity Read ↗

Distinct metabolomic and lipidomic profiles associated with cirrhosis after HCV cure in people with HIV: findings at one and five yearsSemantic proximity Read ↗

Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes.Semantic proximity Read ↗

Impact of common risk factors of fibrosis progression in chronic hepatitis C.Semantic proximity Read ↗

The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.Semantic proximity Read ↗

Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.